Product Catalog

RetatrutideSpecifications & Batch COA

Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.

KERUIHK-0104Retatrutide product vial
Lyophilized PowderProduct image
Weight Loss & Metabolic

Retatrutide

ResearchKERUIHK-0104

Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.

Product Specifications

CAS Number
2381272-77-9
Catalog Purity
≥99.05%
Form
Lyophilized Powder
Catalog Grade
Research
View batch documentation

Product Details

Retatrutide specifications

Use the product name, catalog reference and available specifications below when discussing your requirements with our team.

Product
Retatrutide
Catalog reference
KERUIHK-0104
CAS number
2381272-77-9
Category
Weight Loss & Metabolic
Physical form
Lyophilized Powder

Latest reported batch: Retatrutide

Batch PB-2026-RET-8102 · Oct 11, 2026

Reported appearance
White lyophilized powder
Reported molecular weight / identity
4731.23 Da
Analytical method
RP-HPLC / ESI-MS

Reported analytical results

HPLC Purity
99.31%Report specification: ≥99.0%
Molecular Weight (MS)
4731.23 DaReport specification: 4731.39 ± 0.5 Da
Amino Acid Analysis
ConformsReport specification: Conforms to sequence
Endotoxin (LAL)
0.37 EU/mgReport specification: < 1.0 EU/mg
Show 5 more test results
Sterility (USP <71>)
No growth observedReport specification: No evidence of microbial growth
Residual Solvents
< ICH Q3C limitsReport specification: ICH Q3C Class 2
Water Content (KF)
5.21%Report specification: ≤ 8.0%
Optical Rotation
-29.0 °Report specification: -27° to -33°
Peptide Content (AAA)
96.71%Report specification: ≥95.0%
Source COA: PB-2026-RET-8102-R20261011
Explore this category

Batch Documentation

Certificates of Analysis

Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.

PB-2026-RET-8102Report product: RetatrutideOct 11, 2026 · Reported purity: 99.31%View this batch COA
PB-2026-RET-8102Report product: RetatrutideAug 23, 2026 · Reported purity: 99.5%View this batch COA
PB-2026-RET-0439Report product: RetatrutideJul 08, 2026 · Reported purity: 99.4%View this batch COA
Show 3 earlier reports
PB-2026-RET-0067Report product: RetatrutideApr 10, 2026 · Reported purity: 99.2%View this batch COA
PB-2025-RET-0041Report product: RetatrutideNov 05, 2025 · Reported purity: 99.0%View this batch COA
PB-2025-RET-0019Report product: RetatrutideMar 14, 2025 · Reported purity: 99.1%View this batch COA

Product Inquiry

Request a Retatrutide quotation

We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

Discuss your requirements
Back to all products